Enterprise Value
2.07T
Cash
12.19B
Avg Qtr Burn
N/A
Short % of Float
0.00%
Insider Ownership
0.01%
Institutional Own.
8.25%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ABL001/SCEMBLIX Details Chronic myelomonocytic leukemia, Blood cancer, Cancer, Leukemia | Phase 3 Data readout |